MARINOMED BIOTECH AG INH.
Marinomed Biotech AG, a biopharmaceutical company, develops therapeutic products for indications in virology and immunology in Austria, other European countries, and internationally. It operates through Virology, Immunology, and Other segments. The company's products pipeline includes Budesolv for the treatment of allergic rhinitis; Tacrosolv, which is in Phase II clinical trial for inflammatory … Read more
Market Cap & Net Worth: MARINOMED BIOTECH AG INH. (93Z)
MARINOMED BIOTECH AG INH. (F:93Z) has a market capitalization of $31.16 Million (€30.36 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #25162 globally and #2757 in its home market, demonstrating a 2.80% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying MARINOMED BIOTECH AG INH.'s stock price €16.50 by its total outstanding shares 1839940 (1.84 Million).
MARINOMED BIOTECH AG INH. Market Cap History: 2019 to 2026
MARINOMED BIOTECH AG INH.'s market capitalization history from 2019 to 2026. Data shows change from $188.86 Million to $31.16 Million (-19.18% CAGR).
MARINOMED BIOTECH AG INH. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how MARINOMED BIOTECH AG INH.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 93Z by Market Capitalization
Companies near MARINOMED BIOTECH AG INH. in the global market cap rankings as of March 19, 2026.
Key companies related to MARINOMED BIOTECH AG INH. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
MARINOMED BIOTECH AG INH. Historical Marketcap From 2019 to 2026
Between 2019 and today, MARINOMED BIOTECH AG INH.'s market cap moved from $188.86 Million to $ 31.16 Million, with a yearly change of -19.18%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €31.16 Million | -8.84% |
| 2025 | €34.18 Million | +18.30% |
| 2024 | €28.90 Million | -48.83% |
| 2023 | €56.47 Million | -46.80% |
| 2022 | €106.14 Million | -35.55% |
| 2021 | €164.69 Million | -24.17% |
| 2020 | €217.19 Million | +15.00% |
| 2019 | €188.86 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of MARINOMED BIOTECH AG INH. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $31.16 Million USD |
| MoneyControl | $31.16 Million USD |
| MarketWatch | $31.16 Million USD |
| marketcap.company | $31.16 Million USD |
| Reuters | $31.16 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.